The rising interest in GLP-1 agonists for diabetes has sparked a debate about delivery routes : patches versus pills . Typically, GLP-1 therapies were exclusively available in tablet form, but the https://georgianfdi765280.educationalimpactblog.com/62485284/glp-1-skin-applications-vs-tablets-what-best-for-the-patient